Monozygotic twins with Neurofibromatosis type 1, concordant phenotype and synchronous development of MPNST and metastasis

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Melean, German ^a   Hernández, Alba M ^a   Valero, María C ^a,b   Hernández Imaz, Elisabete ^a   Martín, Yolanda ^a   Hernández Chico, Concepción ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GENOMIC DNA; RNA; NEUROFIBROMIN;

ADULT; ARTICLE; CAFE AU LAIT SPOT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL FEATURE; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; GENE MUTATION; HUMAN; LEG AMPUTATION; LUNG METASTASIS; MACROCEPHALY; MALE; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; MICROSATELLITE MARKER; MONOZYGOTIC TWINS; NERVE SHEATH TUMOR; NEUROFIBROMA; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPOROSIS; PARASPINAL NEUROFIBROMA; PIGEON THORAX; PLEURAL NEUROFIBROMA; POSTOPERATIVE CARE; PSEUDARTHROSIS; PSYCHOMOTOR RETARDATION; RETROPERITONEAL NEUROFIBROMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCIATIC NERVE; SKIN NEUROFIBROMA; THYMUS HYPERPLASIA; TUMOR RECURRENCE; TWIN ZYGOSITY; CASE REPORT; GENETICS; GENOTYPE; LUNG TUMOR; METASTASIS; MUTATION; PATHOLOGY; PHENOTYPE; POLYMERASE CHAIN REACTION; PROGNOSIS;

ADULT; GENOTYPE; HUMANS; LUNG NEOPLASMS; MALE; MUTATION; NERVE SHEATH NEOPLASMS; NEUROFIBROMATOSIS 1; NEUROFIBROMIN 1; PHENOTYPE; POLYMERASE CHAIN REACTION; PROGNOSIS; TWINS, MONOZYGOTIC;

EID: 77955207634     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-407     Document Type: Article

References (24)

1. Ballester R, Marchuk D, Boguski M, Saulino A, Letcher R, Wigler M, Collins F. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 1990, 63:851-859. 10.1016/0092-8674(90)90151-4, 2121371.
2. Williams VC, Lucas J, Babcock MA, Gutmann DH, Korf B, Maria BL. Neurofibromatosis type 1 revisited. Pediatrics 2009, 123:124-133. 10.1542/peds.2007-3204, 19117870.
3. Upadhyaya M, Spurlock G, Monem B, Thomas N, Friedrich RE, Kluwe L, Mautner V. Germline and somatic NF1 gene mutations in plexiform neurofibromas. Hum Mutat 2008, 29:E103-E111. 10.1002/humu.20793, 18484666.
4. Ferner RE, Gutmann DH. International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. Cancer Res 2002, 62:1573-1577.
5. Thomson SA, Fishbein L, Wallace MR. NF1 mutations and molecular testing. J Child Neuro 2002, 17:555-561.
6. Valero MC, Pascual-Castroviejo I, Velasco E, Moreno F, Hernández-Chico C. Identification of de novo deletions at the NF1 gene: no preferential paternal origin and phenotypic analysis of patients. Hum Genet 1997, 99:720-726. 10.1007/s004390050438, 9187663.
7. Pasmant E, Sabbagh A, Spurlock G, Laurendeau I, Grillo E, Hamel MJ, Martin L, Barbarot S, Leheup B, Rodriguez D, Lacombe D, Dollfus H, Pasquier L, Isidor B, Ferkal S, Soulier J, Sanson M, Dieux-Coeslier A, Bièche I, Parfait B, Vidaud M, Wolkenstein P, Upadhyaya M, Vidaud D, . members of the NF France Network NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype. Hum Mutat 2010, 31:E1506-E1518. 10.1002/humu.21271, 20513137, members of the NF France Network.
8. Upadhyaya M, Huson SM, Davies M, Thomas N, Chuzhanova N, Giovannini S, Evans DG, Howard E, Kerr B, Griffiths S, Consoli C, Side L, Adams D, Pierpont M, Hachen R, Barnicoat A, Li H, Wallace P, Van Biervliet JP, Stevenson D, Viskochil D, Baralle D, Haan E, Riccardi V, Turnpenny P, Lazaro C, Messiaen L. An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet 2007, 80:140-151. 10.1086/510781, 1785321, 17160901.
9. Easton DF, Ponder MA, Huson SM, Ponder BA. An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes. Am J Hum Genet 1993, 53:305-301. 1682337, 8328449.
10. Sabbagh A, Pasmant E, Laurendeau I, Parfait B, Barbarot S, Guillot B, Combemale P, Ferkal S, Vidaud M, Aubourg P, Vidaud D, Wolkenstein P, . members of the NF France Network Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1. Hum Mol Genet 2009, 18:2768-2778. 10.1093/hmg/ddp212, 2722187, 19417008, members of the NF France Network.
11. Szudek J, Joe H, Friedman JM. Analysis of intrafamilial phenotypic variation in neurofibromatosis 1 (NF1). Genet Epidemiol 2002, 23:150-164. 10.1002/gepi.1129, 12214308.
12. Szudek J, Evans DG, Friedman JM. Patterns of associations of clinical features in neurofibromatosis 1 (NF1). Hum Genet 2003, 112:289-297.
13. Fahsold R, Hoffmeyer S, Mischung C, Gille C, Ehlers C, Kücükceylan N, Abdel-Nour M, Gewies A, Peters H, Kaufmann D, Buske A, Tinschert S, Nürnberg P. Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. Am J Hum Genet 2000, 66:790-818. 10.1086/302809, 1288164, 10712197.
14. Bahadir C, Gürleyik G, Ocak E. Neurofibromatosis type 1 and primary hyperparathyroidism with spinal deformity and osteoporosis. Acta Chir Belg 2009, 109:123-125.
15. Carroll SL, Ratner N. How does the Schwann cell lineage form tumors in NF1?. Glia 2008, 56:1590-1605. 10.1002/glia.20776, 2652636, 18803326.
16. Thomas L, Kluwe L, Chuzhanova N, Mautner V, Upadhyaya M. Analysis of NF1 somatic mutations in cutaneous neurofibromas from patients with high tumor burden. Neurogenetics
17. Spurlock G, Knight SJ, Thomas N, Kiehl TR, Guha A, Upadhyaya M. Molecular evolution of a neurofibroma to malignant peripheral nerve sheath tumor (MPNST) in an NF1 patient: correlation between histopathological, clinical and molecular findings. J Cancer Res Clin Oncol
18. Miller SJ, Jessen WJ, Mehta T, Hardiman A, Sites E, Kaiser S, Jegga AG, Li H, Upadhyaya M, Giovannini M, Muir D, Wallace MR, Lopez E, Serra E, Nielsen GP, Lazaro C, Stemmer-Rachamimov A, Page G, Aronow BJ, Ratner N. Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. EMBO Mol Med 2009, 1:236-248. 10.1002/emmm.200900027, 20049725.
19. Ottini L, Esposito DL, Richetta A, Carlesimo M, Palmirotta R, Verí MC, Battista P, Frati L, Caramia FG, Calvieri S, Cama A, Mariani-Costantini R. Alterations of microsatellites in neurofibromas of von Recklinghausen's disease. Cancer Res 1995, 55:5677-5680.
20. Scott RH, Mansour S, Pritchard-Jones K, Kumar D, MacSweeney F, Rahman N. Medulloblastoma, acute myelocytic leukemia and colonic carcinomas in a child with biallelic MSH6 mutations. Nat Clin Pract Oncol 2007, 4:130-134. 10.1038/ncponc0719, 17259933.
21. Bandipalliam P. Syndrome of early onset colon cancers, hematologic malignancies & features of neurofibromatosis in HNPCC families with homozygous mismatch repair gene mutations. Fam Cancer 2005, 4:323-333. 10.1007/s10689-005-8351-6, 16341812.
22. Lubinsky MS. Non-random associations and vascular fields in neurofibromatosis 1: a pathogenetic hypothesis. Am J Med Genet A 2006, 140:2080-2084.
23. Wistuba II, Tomlinson GE, Behrens C, Virmani A, Geradts J, Blum JL, Minna JD, Gazdar AF. Two identical triplet sisters carrying a germline BRCA1 gene mutation acquire very similar breast cancer somatic mutations at multiple other sites throughout the genome. Genes Chromosomes Cancer 2000, 28:359-369. 10.1002/1098-2264(200008)28:4<359::AID-GCC1>3.0.CO;2-N, 10862044.
24. Delgado L, Fernández G, González A, Bressac-de Paillerets B, Gualco G, Bombled J, Cataldi S, Sabini G, Roca R, Musé IM. Hereditary breast cancer associated with a germline BRCA2 mutation in identical female twins with similar disease expression. Cancer Genet Cytogenet 2002, 133:24-28. 10.1016/S0165-4608(01)00541-6, 11890985.